Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Patients with a specific genetic variant have more severe alopecia areata and higher recurrence rates.

A chimeric keratin partially improved skin structure in mice lacking keratin 5, but didn't fully restore normal skin.

Atopic diseases worsen alopecia areata, leading to earlier onset and more severe forms.

More lesions mean more severe alopecia areata.

Proper diet management is crucial for preventing severe symptoms in phenylketonuria.

Alopecia areata is becoming more common in Japan, with a need for better treatments, especially for severe and pediatric cases.

Tofacitinib effectively treats severe alopecia areata, improving hair regrowth and patient satisfaction.

Olumiant should be covered for severe alopecia areata if certain conditions are met.

Baricitinib helps keep hair, eyebrows, and eyelashes regrown for 3 years in most people with severe hair loss.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

The treatment is effective and safe for severe alopecia areata in children, but not for total or universal hair loss.

A gene mutation in mice causes hair loss, weak bones, and protein buildup, showing how protein processing issues can lead to diseases.

JAK inhibitors effectively treat severe atopic dermatitis and alopecia areata.

Oral and topical tofacitinib can effectively treat severe hair loss with minimal side effects.

Lower zinc levels are linked to more severe hair loss in alopecia areata.

Azathioprine may be an effective treatment for severe hair loss.

Ritlecitinib is effective for long-term treatment of severe alopecia areata.

Combining oral minoxidil with JAK inhibitors helps regrow hair in severe alopecia areata cases.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

IBD patients treated with TNF antagonists may develop autoimmune alopecia areata, with severe cases less likely to improve.

A new mix of anthralin and calcipotriene might help treat severe hair loss.

Alopecia areata patients, especially with severe forms, have a higher risk of cardiovascular disease.

Atopic dermatitis may trigger alopecia areata, and early treatment can help prevent severe cases.

308 nm excimer lamp therapy is effective for alopecia areata but less so for severe cases.

Dupilumab may help regrow hair in people with severe alopecia.

Experts recommend starting systemic treatment for alopecia areata when the condition is severe or causes significant distress.

A COVID-19 vaccine may trigger severe hair loss in rare cases.

An 11-year-old girl with severe hair loss was successfully treated with a new combination therapy.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.